JP2024510939A5 - - Google Patents
Info
- Publication number
- JP2024510939A5 JP2024510939A5 JP2023553301A JP2023553301A JP2024510939A5 JP 2024510939 A5 JP2024510939 A5 JP 2024510939A5 JP 2023553301 A JP2023553301 A JP 2023553301A JP 2023553301 A JP2023553301 A JP 2023553301A JP 2024510939 A5 JP2024510939 A5 JP 2024510939A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- alkyl
- compound according
- regulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156164P | 2021-03-03 | 2021-03-03 | |
| US63/156,164 | 2021-03-03 | ||
| PCT/US2022/018321 WO2022187231A1 (en) | 2021-03-03 | 2022-03-01 | Arylsulfoxamides as orexin receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510939A JP2024510939A (ja) | 2024-03-12 |
| JP2024510939A5 true JP2024510939A5 (https=) | 2025-03-10 |
Family
ID=83154799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553301A Pending JP2024510939A (ja) | 2021-03-03 | 2022-03-01 | オレキシン受容体アゴニストとしてのアリールスルホンアミド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240174605A1 (https=) |
| EP (1) | EP4301728A4 (https=) |
| JP (1) | JP2024510939A (https=) |
| CN (1) | CN117015526B (https=) |
| AU (1) | AU2022229350A1 (https=) |
| CA (1) | CA3208567A1 (https=) |
| MX (1) | MX2023009452A (https=) |
| WO (1) | WO2022187231A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI4065585T3 (fi) | 2019-11-25 | 2025-09-26 | Alkermes Inc | Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8258163B2 (en) | 2008-06-04 | 2012-09-04 | Board Of Regents, The University Of Texas System | Small-molecule agonists for type-2 orexin receptor |
| PE20161064A1 (es) * | 2013-12-12 | 2016-10-28 | Univ Tsukuba | Derivado de sulfonamida o sales de adicion de acido farmaceuticamente aceptables del mismo |
| WO2016133160A1 (ja) * | 2015-02-19 | 2016-08-25 | 国立大学法人筑波大学 | スルホンアミド誘導体またはその薬学的に許容される酸付加塩 |
| WO2016199906A1 (ja) * | 2015-06-12 | 2016-12-15 | 国立大学法人筑波大学 | スルホンアミド誘導体またはその薬学的に許容される酸付加塩 |
| WO2019117148A1 (ja) * | 2017-12-12 | 2019-06-20 | 国立大学法人 筑波大学 | スルホンアミド誘導体またはその薬学的に許容される酸付加塩 |
| MX2020010155A (es) * | 2018-03-27 | 2021-03-25 | Univ Texas | Compuestos de ox2r. |
| US11098029B2 (en) | 2019-02-13 | 2021-08-24 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
-
2022
- 2022-03-01 US US18/279,985 patent/US20240174605A1/en active Pending
- 2022-03-01 WO PCT/US2022/018321 patent/WO2022187231A1/en not_active Ceased
- 2022-03-01 JP JP2023553301A patent/JP2024510939A/ja active Pending
- 2022-03-01 AU AU2022229350A patent/AU2022229350A1/en active Pending
- 2022-03-01 CN CN202280018638.0A patent/CN117015526B/zh active Active
- 2022-03-01 CA CA3208567A patent/CA3208567A1/en active Pending
- 2022-03-01 EP EP22763891.3A patent/EP4301728A4/en active Pending
- 2022-03-01 MX MX2023009452A patent/MX2023009452A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510939A5 (https=) | ||
| CN115867533B (zh) | 色胺前药 | |
| ES2243441T3 (es) | Derivados de imidazolio fundidos. | |
| CA2326833C (en) | Indolyl-3-glyoxylic acid derivatives with antitumoral activity | |
| JPWO2022138987A5 (https=) | ||
| WO2001025190A1 (en) | Novel diarylamide derivatives and use thereof as medicines | |
| JP2022545359A5 (https=) | ||
| CN113831301B (zh) | 苯并噻唑类衍生物及其用途 | |
| JP4477097B2 (ja) | 中枢神経系障害の治療のための（２ｓ）−（４ｅ）−ｎ−メチル−５−［３−（５−イソプロポキシピリジン）イル］−４−ペンテン−２−アミンの多形形態 | |
| HUP0303317A2 (hu) | Orto, meta-szubsztituált biszarilszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények | |
| RU2014131014A (ru) | Димерные соединения-агонисты рецептора fgf (fgfr), способ их получения и их терапевтическое применение | |
| TW394769B (en) | Acylaminoindole derivatives, intermediates for their preparation, and pharmaceutical compositions containing them | |
| TW200846004A (en) | Process for the preparation of piperazinyl and diazepanyl benzamide derivatives | |
| JP2023544716A5 (https=) | ||
| CA2568608A1 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
| JP2013542267A5 (https=) | ||
| JOP20240217A1 (ar) | مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة | |
| JP2024514366A (ja) | 可溶性エポキシドヒドロラーゼ阻害剤としてのピペリジン尿素誘導体 | |
| JP2022527618A5 (https=) | ||
| ES2222029T3 (es) | Derivados de benzofuroxano y su uso en el tratamiento de angina de pecho. | |
| CN101365461B (zh) | 舒林酸衍生物、其用途和其制备 | |
| JP2005533038A5 (https=) | ||
| TW496737B (en) | Improving the tolerability of pharmaceutically active β-amino acids | |
| JP2021523915A5 (https=) | ||
| JP2007507473A5 (https=) |